Sun Pharma, Novartis settle lawsuit over Glivec

Sun Pharma allowed to launch generic version of anti-leukamia drug next year

Novartis loses patent appeal in landmark suit

Supreme Court upholds amended law that bars patents for insignificant improvements to an existing drug—in this case anti-cancer drug …

Evergreen Novartis

The Swiss pharma giant’s challenge to India’s patent law, now in the Supreme Court, may help define drug efficacy